Capital · out
outflows — medical + PBM drug costs dominate; then ~$3.6B buybacks + ~$1.6B dividends FY25
Sourced figures 1
- stockanalysis.com CI cash-flow statement share repurchases $3,621M; dividends paid $1,611M FY25; FCF $8,389M FY25
the working
Threads 1
A claim is one metric we assert about a node — the value is the summary, this page is the receipt. Sourced from kestrel; supersedes-history not yet shown. Back to Cigna.